1256931

Berkeley Advanced Biomaterials, LLC — FEI 3014298539

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Berkeley, CA (United States)

Citations

IDCFRDescription
1236321 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
1238721 CFR 1271.220(a)Causing contamination, increasing risks
1243721 CFR 1271.270(a)Records incomplete